Palomino Laboratories (PALX) Notes Payables (2022 - 2025)
Palomino Laboratories recorded quarterly Notes Payables of $20000.0 in Q2 2025, up 536.94% quarter-over-quarter from $3140.0 in Q4 2024, and down 81.85% year-over-year from $110204.0 in Q2 2024.
Palomino Laboratories' Notes Payables history runs 4 years deep, the most recent figure standing at $20000.0 for Q2 2025.
- In Q2 2025, Notes Payables fell 81.85% year-over-year to $20000.0; the TTM figure through Jun 2025 stood at $20000.0 (down 81.85% YoY), while the FY2024 annual figure was $3140.0, down 68.6% from the prior year.
- Notes Payables came in at $20000.0 for Q2 2025 at Palomino Laboratories, up from $3140.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $130247.0 in Q3 2024 to a low of $304.0 in Q4 2022.
- A 4-year average of $38492.8 and a median of $15625.0 in 2024 frame the typical range for Notes Payables.
- Across the five-year window, Notes Payables jumped 3189.47% in 2023 and slumped 81.85% in 2025, its largest moves.
- Palomino Laboratories' Notes Payables stood at $304.0 in 2022, then surged by 3189.47% to $10000.0 in 2023, then plunged by 68.6% to $3140.0 in 2024, then soared by 536.94% to $20000.0 in 2025.
- According to Business Quant data, Notes Payables over the past three periods registered $20000.0, $3140.0, and $130247.0 for Q2 2025, Q4 2024, and Q3 2024 respectively.
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 275,000.00 |
| Dec 31, 2024 | 3,140.00 |
| Sep 30, 2024 | 130,247.00 |
| Jun 30, 2024 | 110,204.00 |
| Mar 31, 2024 | 79,563.00 |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | 22,797.00 |
| Dec 31, 2022 | 5,000.00 |